SCHEMBL30725482

SCHEMBL30725482

Nc1ccc(Cn2cc(Nc3ncc(Cl)c(C(F)(F)F)n3)cn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 12/20 0.51
HDAC3 O15379 11/20 0.51
HDAC1 Q13547 11/20 0.51
HDAC6 Q9UBN7 10/20 0.51
HDAC4 P56524 9/20 0.51
HDAC7 Q8WUI4 9/20 0.51
HDAC2 Q92769 9/20 0.51
HDAC10 Q969S8 9/20 0.51
HDAC11 Q96DB2 9/20 0.51
HDAC8 Q9BY41 9/20 0.51
HDAC9 Q9UKV0 9/20 0.51
HDAC5 Q9UQL6 9/20 0.51
KDR P35968 1/20 0.43
AURKB Q96GD4 1/20 0.43
FLT4 P35916 1/20 0.40
JAK3 P52333 6/20 0.40
RPS6KB1 P23443 1/20 0.40
FLT3 P36888 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29174660 1.00 JAK2 (0.51) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174593 0.87 HDAC3 (0.49) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL30725478 0.87 HDAC3 (0.49) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174600 0.85 MEN1 (0.50) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174717 0.83 JAK2 (0.43) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174723 0.81 JAK3 (0.61) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL30725464 0.80 HDAC3 (0.50) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174614 0.80 HDAC3 (0.50) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL29174734 0.80 HDAC3 (0.51) JAK2HDAC3HDAC1HDAC6HDAC4
SCHEMBL30725437 0.80 HDAC3 (0.51) JAK2HDAC3HDAC1HDAC6HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117430589-A 2-aminopyrimidine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-01-23 CN disclosed